Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies
A novel clinical assay for the detection and quantitation of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was adapted from an in-house, research-based enzyme-linked immunosorbent assay (ELISA). Development and validation were performed under regulatory guidelines,...
Guardado en:
Autores principales: | Magdalena M. Żak, Aryeh Stock, Daniel Stadlbauer, Wei Zhang, Kirstie Cummings, William Marsiglia, Arsen Zargarov, Fatima Amanat, Monica Tamayo, Carlos Cordon-Cardo, Florian Krammer, Damodara Rao Mendu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c72781bae044eaf93031c713d193335 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
por: Dinesh Mohanraj, et al.
Publicado: (2021) -
Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020
por: Cheng Xiao, et al.
Publicado: (2021) -
Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans IgG Subclass Antibody Levels as Immunological Risk Indicators of Chronic Periodontitis: A Multilevel Approach
por: Ardila,Carlos M, et al.
Publicado: (2013) -
Vaccines, Repurposed Drugs and Alternative Biomedicines for the Management and Prevention of COVID-19
por: Jeyalakshmi Kandhavelu, et al.
Publicado: (2021) -
Diagnostic Value of Immunoglobulin A and M antibodies as a disease Marker for hepatitis A Infection
por: Medhat Haroun,, et al.
Publicado: (2007)